Semax/Selank 10mg Lyophylized Powder

Semax 5mg/Selank 5mg 
This blend is supplied for laboratories conducting comparative cellular researchinvolving both Semax and Selank. The combined formulation allows researchers to study both compounds within a single sample preparation, streamlining laboratory workflows for parallel and comparative short-chain neuropeptide research investigations.

Both Semax and Selank were originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and have been studied extensively in peer-reviewed research published by the Myasoedov research group and other Russian peptide research laboratories. Foundational research is available through PubMed (pubmed.ncbi.nlm.nih.gov) and the National Institutes of Health’s PMC database (pmc.ncbi.nlm.nih.gov), where researchers can access peer-reviewed studies on each compound independently.